Method for simultaneously determining contents of various components in oral liquid for treating hemiplegia

The UPLC method simultaneously determines Wangbulixing flavonoid glycoside and danphenolic acid B in hemiplegia oral solution, which solves the problem that cannot be effectively measured in the prior art, and achieves a comprehensive and accurate detection and evaluation of the quality of hemiplegia oral solution. Advantages of simplicity, stability and repeatability.

CN118961922APending Publication Date: 2024-11-15LIUZHOU HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411041222.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

The prior art cannot effectively determine the content of various components in hemiplegia oral solution at the same time, especially the content of Wangbulien flavonoid glycoside and sanphenolic acid B, which leads to difficulty in controlling the preparation quality.

Method used

UPLC method was used, using InertSustainAQ-C18 chromatography column, methanol-0.6% phosphoric acid gradient elution program, column temperature was 30°C, flow rate was 1 mL/min, and the detection wavelength was 280 nm. The injection volume of the reference solution and the test sample solution was 10 μl, achieving simultaneous determination of flavonoid glycoside and sanphenolic acid B.

Benefits of technology

It has achieved comprehensive and accurate detection of flavonoid glycosides and sanphenolic acid B in hemiplegia oral solution. It has the advantages of simple method, good stability and good repeatability, and is suitable for the quality control of hemiplegia oral solution.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118961922A_ABST
    Figure CN118961922A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of traditional Chinese medicine detection, in particular to a method for simultaneously determining contents of various components in oral liquid for hemiplegia. According to the method, a UPLC (Ultra Performance Liquid Chromatography) method is adopted, a chromatographic column is InertSustainAQ-C18 (4.6 * 250 mm, 5 [mu] m), a mobile phase is methanol (A)-0.6% phosphoric acid (B), gradient elution is carried out for 0-10 min, 25% (A); 10-40 min, 25%-40% (A); 40%-37% (A) in 40-41 min; 41-96 min, 37%-37% (A); the column temperature is 30 DEG C; the flow velocity is 1mL / min; the detection wavelength is 280 nm; the sample size is 10 microliters. According to the method disclosed by the invention, the cowherb seed flavonoid glycoside and the salvianolic acid B in the oral liquid for hemiplegia can be simultaneously separated and determined, the quality condition of the oral liquid for hemiplegia in the hospital can be relatively comprehensively, objectively and accurately detected and evaluated, and the method disclosed by the invention has the advantages of simplicity, convenience, good stability, good repeatability, high precision and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicine detection, in particular to a method for simultaneously determining the contents of multiple components in a hemiplegia oral liquid. Background Art

[0002] Hemiplegia oral liquid is a traditional Chinese medicine compound preparation made by our hospital. It is composed of 6 traditional Chinese medicines, namely earthworm, salvia miltiorrhiza, safflower, chuanxiong, fenugreek and liquorice. It has the effects of promoting blood circulation and removing blood stasis, unblocking meridians and detoxifying. It is often used to treat ischemic stroke, hemiplegia due to stroke, and cardiovascular diseases of qi deficiency and blood stasis type, with significant clinical efficacy. The main medicines in the prescription, salvia miltiorrhiza and earthworm, are commonly used blood circulation and blood stasis drugs. Both of them are cool in nature. When used together, they can enhance the effects of promoting blood circulation and removing blood stasis, clearing away heat and detoxifying, unblocking meridians and removing dampness, and reducing swelling and relieving pain. They are often used to treat various symptoms of blood stasis and blood deficiency. Modern pharmacological studies have shown that salvia miltiorrhiza mainly contains salvianolic acids and tanshinones, which have pharmacological effects such as protecting the cardiovascular and cerebrovascular system, anti-inflammatory, anti-oxidation, and scavenging free radicals; earthworm mainly contains organic acids, which can protect the cardiovascular and cerebrovascular system, enhance hematopoietic function, and improve immune function. The ministerial herbs, Rhizoma Chuanxiong, can promote blood circulation and qi, dispel wind and relieve pain, promote blood circulation and remove blood stasis, and relieve pain; the adjuvant herb, Safflower, has the effects of promoting blood circulation and removing blood stasis, moisturizing and relieving pain, reducing swelling and stopping bleeding, and promoting blood stasis and removing swelling. Safflower is often used in folk medicine for analgesia, anti-inflammatory, and improving microcirculation. Licorice is the guiding herb, which harmonizes the effects of the other herbs, fully reflecting the prescription principle of monarch, minister, assistant, and guiding.

[0003] Among them, the main ingredients, flavonoids of Vaccariae and salvianolic acid B, play an important role. Vaccariae flavonoids and salvianolic acid B are not only the index ingredients of Vaccariae and Salviae Miltiorrhizae respectively stipulated in the Chinese Pharmacopoeia, but also we found through network pharmacology combined with experimental verification that Vaccariae flavonoids and salvianolic acid B are the main effective ingredients of hemiplegia oral solution for the treatment of ischemic stroke. Therefore, whether based on the basis of the Chinese Pharmacopoeia or network pharmacology research, it is suggested that Vaccariae flavonoids and salvianolic acid B have great potential for the efficacy and quality control of hemiplegia oral solution. And because the effective ingredients of traditional Chinese medicine compound preparations are complex and diverse, the content determination of a single ingredient cannot control the quality of the preparation as a whole, that is, the quality control of multiple index ingredients should be gradually applied to quality control.

[0004] Therefore, it is urgently needed to develop a method that can simultaneously determine multiple components such as fenugreek flavonoid glycosides and salvianolic acid B in hemiplegia oral liquid. Summary of the invention

[0005] In order to solve the above technical problems existing in the prior art, the present invention provides a method for simultaneously determining the contents of multiple components in hemiplegia oral liquid, which is as follows:

[0006] A method for simultaneously determining the contents of multiple components in a hemiplegia oral liquid is disclosed, wherein the UPLC method is used for determination, and the specific chromatographic conditions are as follows: the chromatographic column is InertSustainAQ-C18 (4.6×250 mm, 5 μm), and the mobile phase is methanol (A)-0.6% phosphoric acid (B).

[0007] Furthermore, the hemiplegia oral liquid is a compound Chinese medicine preparation made by Liuzhou Traditional Chinese Medicine Hospital, which is composed of six Chinese medicinal herbs: earthworm, salvia miltiorrhiza, safflower, chuanxiong, fenugreek, and licorice.

[0008] Furthermore, the contents of the multiple components are determined, specifically, fenugreek flavonoid glycosides and salvianolic acid B.

[0009] Furthermore, the specific elution procedure of the UPLC method is as follows: gradient elution: 0-10 min, 25% (A); 10-40 min, 25%-40% (A); 40-41 min, 40%-37% (A); 41-96 min, 37%-37% (A).

[0010] Furthermore, the specific conditions of the UPLC method are as follows: column temperature 30°C; flow rate 1 mL / min; detection wavelength 280 nm.

[0011] Further, the mixed reference solution is a mixed reference solution with 50% methanol as solvent, and the concentrations of vaccaria flavonoid glycosides and salvianolic acid B are 50.99 μg / mL and 178.91 μg / mL, respectively. Preferably, the specific preparation method of the mixed reference solution is as follows: vaccaria flavonoid glycosides and salvianolic acid B are respectively taken into a volumetric bottle, methanol is added to dissolve and dilute to the scale, and 1274.87 μg / mL of vaccaria flavonoid glycosides and 1118.19 μg / mL of salvianolic acid B reference substance stock solution are obtained, 0.2 mL of vaccaria flavonoid glycosides reference substance stock solution and 0.8 mL of salvianolic acid B reference substance stock solution are taken into a 5 mL volumetric bottle, and 50% methanol is added to prepare a mixed reference solution with the concentrations of vaccaria flavonoid glycosides and salvianolic acid B being 50.99 μg / mL and 178.91 μg / mL, respectively.

[0012] Furthermore, the test solution is obtained by diluting the hemiplegia oral solution with water, mixing it evenly, and filtering it. Specifically, 5 mL of the hemiplegia oral solution is placed in a 25 mL volumetric bottle, diluted to the mark with water, mixing it evenly, and filtering it to obtain the test solution.

[0013] Furthermore, the injection volume of the mixed reference solution and the test solution was 10 μl.

[0014] Compared with the prior art, the technical effects created by the present invention are embodied in:

[0015] The present invention adopts UPLC method, the chromatographic column is InertSustainAQ-C18 (4.6×250mm, 5μm), the mobile phase is methanol (A)-0.6% phosphoric acid (B), gradient elution: 0-10min, 25% (A); 10-40min, 25%-40% (A); 40-41min, 40%-37% (A); 41-96min, 37%-37% (A); column temperature 30°C; flow rate 1mL / min; detection wavelength 280nm; injection volume 10μl. According to the method of the present invention, the flavonoid glycosides of Vaccariae and salvianolic acid B in the hemiplegia oral liquid can be separated and determined at the same time, and the quality of the hemiplegia oral liquid prepared by the hospital can be detected and evaluated more comprehensively, objectively and accurately, and the method of the present invention has the advantages of simple method, good stability, good repeatability, high precision and the like. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 This is the chromatogram of hemiplegia oral liquid, where: A is a mixed reference substance, B is a test substance; 1 is vaccaria flavonoid glycoside, 2 is salvianolic acid B. DETAILED DESCRIPTION

[0017] The technical solution of the present invention is further defined below in conjunction with specific implementation methods, but the scope of protection required is not limited to the description.

[0018] Example:

[0019] Determination of content limit of hemiplegia oral solution

[0020] 1. Instruments and Materials

[0021] 1.1 Instrument

[0022] SHIMADZU LC-40D XR high performance liquid chromatograph (Shimadzu Corporation, Japan); SPD-M40 diode array detector (Shimadzu Corporation, Japan); L5 ultraviolet spectrophotometer (Shanghai Yidian Analytical Instrument Co., Ltd.); BCE95PI-10CN 1 / 100,000 electronic balance (Sartorius Scientific Instrument Co., Ltd.); KQ5200E ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); GWB-1B ultrapure water machine (Beijing Puxi General Instrument Co., Ltd.);

[0023] 1.2 Materials

[0024] Vaccariae flavonoid glycosides (MUST-24042122, 99.99%) and salvianolic acid B (MUST-23061219, 98.78%) were purchased from Chengdu Mansite Biotechnology Co., Ltd.; methanol (chromatographic grade, Furton Science and Technology Co., Ltd.) and water were purified water, and other reagents were of analytical grade; hemiplegia oral solution (20230502, 20230901, 20230701, 20231001, 20231101, 20230501, 20230101, 20240601) was provided by the preparation room of Liuzhou Hospital of Traditional Chinese Medicine (Liuzhou Zhuang Medicine Hospital);

[0025] 2 Methods and Results

[0026] 2.1 Chromatographic conditions

[0027] The chromatographic column was InertSustainAQ-C18 (4.6×250mm, 5μm), the mobile phase was methanol (A)-0.6% phosphoric acid (B), gradient elution: 0-10min, 25% (A); 10-40min, 25%-40% (A); 40-41min, 40%-37% (A); 41-96min, 37%-37% (A); column temperature 30°C; flow rate 1mL / min; detection wavelength 280nm.

[0028] 2.2 Preparation of mixed reference solution

[0029] Separately take 12.75 mg of vaccaria flavonoid glycosides (MUST-24042122, 99.99%) and 11.32 mg of salvianolic acid B (MUST-23061219, 98.78%) into a 10 mL volumetric flask, add methanol to dissolve and dilute to the scale to obtain 1274.87 μg / mL of vaccaria flavonoid glycosides and 1118.19 μg / mL of salvianolic acid B reference substance stock solutions, take 0.2 mL of vaccaria flavonoid glycosides reference substance stock solution and 0.8 mL of salvianolic acid B reference substance stock solution into a 5 mL volumetric flask, add 50% methanol to prepare a mixed reference substance solution with concentrations of vaccaria flavonoid glycosides and salvianolic acid B of 50.99 μg / mL and 178.91 μg / mL, respectively.

[0030] 2.3 Preparation of test samples

[0031] Take 5 mL of hemiplegia oral solution, place it in a 25 mL volumetric flask, add water to dilute to the scale, mix well, filter, and the test solution is obtained.

[0032] 2.4 Determination method

[0033] Accurately pipette 10 μl of the mixed reference solution and the test solution, inject into the liquid chromatograph, and measure. (See the chromatogram for details.) Figure 1 )

[0034] 2.5 Determination of standard curve

[0035] 2.5, 5, 10, 15, 20 μL of the mixed reference solution were injected into the liquid chromatograph, with mass concentration (X, μg / mL) as the abscissa and peak area (Y) as the ordinate, and the standard curve equations were obtained as follows: Vaccaria flavonoid glycosides Y = 13126X-5203.3, r2 = 1; Salvianolic acid BY = 11952X-14339, r2 = 1. The results showed that Vaccaria flavonoid glycosides had a good linear relationship in the range of 12.75-101.99 μg / mL and Salvianolic acid B in the range of 44.73-357.82 μg / mL.

[0036] 2.6 Precision test

[0037] Take the same hemiplegia test solution, inject it 6 times in a row, and record the peak area. The results show that the RSD of the peak area of ​​flavonoid glycosides of Vaccariae and salvianolic acid B are 0.88% and 0.60% respectively, indicating that the instrument has good precision.

[0038] 2.7 Stability test

[0039] The same hemiplegia test solution was taken and sampled at 0, 2, 4, 8, 12, and 24 hours, and the peak areas were recorded. The calculation results showed that the RSDs of the peak areas of Vaccariae flavonoid glycosides and Salvianolic acid B were 0.88% and 0.62%, respectively, indicating that the test sample was stable within 24 hours.

[0040] 2.8 Repeatability test

[0041] Take 6 samples and prepare 6 sample solutions, inject them separately and calculate the concentration. The results show that the average contents of flavonoid glycosides of Vaccariae and salvianolic acid B are 237.11μg / mL and 1142.19μg / mL, respectively, and the RSDs are 0.46% and 0.66%, respectively, indicating that the method has good repeatability.

[0042] 2.9 Sample recovery test

[0043] Take 2.5mL of the test sample with known content, add appropriate amount of Vaccaria flavonoid glycosides and salvianolic acid B reference substances, prepare the test solution in 6 parallel batches, measure, and calculate the recovery rate of the sample. The average recovery rates of Vaccaria flavonoid glycosides and salvianolic acid B were 103.30% and 99.01%, respectively, and the RSDs were 0.87% and 1.73%, respectively, indicating that the determination method is accurate and reliable. (See Table 1)

[0044] Table 1 Hemiplegia oral liquid sample recovery test

[0045]

[0046] 3. Establishment of content limits

[0047] Eight batches of hemiplegia oral solution (batch number: 20230502, 20230901, 20230701, 20231001, 20231101, 20230501, 20230101, 20240601) were selected to prepare the test solution, which was injected into the liquid chromatograph for determination, and the contents of flavonoid glycosides of Vaccaria and salvianolic acid B were calculated. The results are shown in Table 2. The average contents of flavonoid glycosides of Vaccaria and salvianolic acid B were 206.76 μg / mL and 887.75 μg / mL, respectively. The content limit was temporarily set at 80% of the lowest content value in the 8 batches of samples tested, with 142.02 μg / mL of flavonoid glycosides of Vaccaria and 512.95 μg / mL of salvianolic acid B.

[0048] Table 2 Content determination results of 8 batches of hemiplegia oral liquid

[0049]

[0050] It can be seen from the above that the method of the present invention can well separate the vaccaria flavonoid glycosides and salvianolic acid B in the hemiplegia oral liquid, and the method is simple, accurate and has good repeatability, and can be used for the content determination of vaccaria flavonoid glycosides and salvianolic acid B in the hemiplegia oral liquid, providing a reference for the quality control of the hemiplegia oral liquid.

[0051] Finally, it should be pointed out that the above embodiments are only representative examples of the present invention. Obviously, the technical solution of the present invention is not limited to the above embodiments, and there are many variations. All variations that can be directly derived or associated with the content disclosed by ordinary technicians in this field should be considered as the protection scope of the present invention.

Claims

1. A method for simultaneously determining the contents of multiple components in hemiplegia oral solution. It is characterized in that The UPLC method was used for determination, and the specific chromatographic conditions were as follows: the chromatographic column was InertSustain AQ-C18 (4.6×250 mm, 5 μm), and the mobile phase was methanol (A)-0.6% phosphoric acid (B).

2. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The hemiplegia oral liquid is composed of 6 Chinese medicinal materials: earthworm, salvia miltiorrhiza, safflower, chuanxiong, fenugreek and liquorice.

3. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The contents of the multiple components are specifically determined for fenugreek flavonoid glycosides and salvianolic acid B.

4. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The specific elution procedure of the UPLC method is as follows: gradient elution: 0-10 min, 25% (A); 10-40 min, 25%-40% (A); 40-41 min, 40%-37% (A); 41-96 min, 37%-37% (A).

5. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The specific conditions of the UPLC method are as follows: column temperature 30°C; flow rate 1 mL / min; detection wavelength 280 nm.

6. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The mixed reference solution is a mixed reference solution using 50% methanol as solvent, and the concentrations of fenugreek flavonoid glycosides and salvianolic acid B are 50.99 μg / mL and 178.91 μg / mL, respectively.

7. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The mixed reference solution is prepared by respectively taking vaccaria flavonoid glycosides and salvianolic acid B into a volumetric flask, adding methanol to dissolve and dilute to the scale to obtain 1274.87 μg / mL of vaccaria flavonoid glycosides and 1118.19 μg / mL of salvianolic acid B reference substance stock solutions, taking 0.2 mL of vaccaria flavonoid glycosides reference substance stock solution and 0.8 mL of salvianolic acid B reference substance stock solution into a 5 mL volumetric flask, adding 50% methanol to prepare a mixed reference solution with the concentrations of vaccaria flavonoid glycosides and salvianolic acid B being 50.99 μg / mL and 178.91 μg / mL, respectively.

8. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The test solution is prepared by diluting the hemiplegia oral solution with water, mixing the diluted solution evenly, and filtering the solution.

9. The method for simultaneously determining the contents of multiple components in the hemiplegia oral liquid according to claim 1, It is characterized in that The injection volume was 10 μl.